Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Dalnicastobart, an antibody targeting TNFRSF5.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Anzurstobart, an antibody targeting SIRPA.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Calpurbatug, an antibody targeting Bacteria Proteins HU and IHF.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Xirestomig, an antibody targeting PD-L1 × 4-1BB.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Opugotamig, an antibody targeting Folate receptor alpha.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Lanerkitug, an antibody targeting CCR8.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Mipletamig, an antibody targeting IL3RA × CD3E.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Precemtabart, an antibody targeting CEACAM5.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ragistomig, an antibody targeting PD-L1 × 4-1BB.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Lumistobart, an antibody targeting SIRPA.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Lancastotug, an antibody targeting TIGIT.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Luvagrobart, an antibody targeting NGF.